Updated combined analysis of two phase II studies of brentuximab vedotin in patients with mycosis fungoides and Sezary syndrome

著录项

• 来源
  《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2018年第2018期|共1页
• 作者

  Huen Auris; Rahbar Z.; Talpur R.; Li S.; Hong E. K.; Tetzlaff M.; Duvic M.; Kim Y. H.;

  展开▼
• 作者单位

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Stanford Canc Inst Stanford CA USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Stanford Canc Inst Stanford CA USA;

  Stanford Canc Inst Stanford CA USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Stanford Canc Inst Stanford CA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词